Advanced glycation end products assessed by skin autofluorescence: A new marker of diabetic foot ulceration

Diabetes Technology and Therapeutics

Volumn 15, Issue 7, 2013, Pages 601-605

  Vouillarmet, Julien ^a   Maucort Boulch, Delphine ^b,c,d   Michon, Paul ^a   Thivolet, Charles ^a,e  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^e CarMeN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; ARTICLE; AUTOFLUORESCENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC NEUROPATHY; FEMALE; FOOT CARE; HEALING; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; SKIN AUTOFLUORESCENCE;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; OVERWEIGHT; PERIPHERAL NERVOUS SYSTEM DISEASES; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN; SPECTROMETRY, FLUORESCENCE; WOUND HEALING;

EID: 84880276278     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0009     Document Type: Article

References (34)

1. Boulton AJ: The diabetic foot: Grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev 2008;24(Suppl 1):S3-S6
2. Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Uccioli L, Urbancic V, Bakker K, Holstein P, Jirkovska A, Piaggesi A, Ragnarson-Tennvall G, Reike H, Spraul M, Van Acker K, Van Baal J, Van Merode F, Ferreira I, Huijberts M: Prediction of outcome in individuals with diabetic foot ulcers: Focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia 2008;51:747-755
3. Stevens MJ, Edmonds ME, Douglas SLE, Watkins PJ: Influence of neuropathy on the microvascular response to local heating in the human diabetic foot. Clin Sci 1991;80:249-256
4. Tahrani AA, Zeng W, Shakher J, Piya MK, Hughes S, Dubb K, Stevens MJ: Cutaneous structural and biochemical correlates of foot complications in high-risk diabetes. Diabetes Care 2012;35:1913-1918
5. Peters EJ, Lavery LA; International Working Group on the Diabetic Foot: Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2001;24:1442-1447
6. Lavery LA, Peters EJ, Williams JR, Murdoch DP, Hudson A, Lavery DC; International Working Group on the Diabetic Foot: Reevaluating the way we classify the diabetic foot: Restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2008;31:154-156
7. Peters EJ, Armstrong DG, Lavery LA: Risk factors for recurrent diabetic foot ulcers. Diabetes Care 2007;30:2077-2079
8. Mantey I, Foster AVM, Spencer S, Edmonds ME: Why do foot ulcers recur in diabetic patients? Diabet Med 1999;16:245-249
9. Faglia E, Favales F, Morabito A: New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993. Diabetes Care 2001;24:78-83
10. Brownlee M: The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005;54:1615-1625
11. Peppa M, Stavroulakis P, Raptis SA: Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen 2009;17:461-472
12. Huijberts MS, Schaper NC, Schalkwijk CG: Advanced glycation end products and diabetic foot disease. Diabetes Metab Res Rev 2008;24(Suppl 1):S19-S24
13. Abate M, Schiavone C, Pelotti P, Salini V: Limited joint mobility in diabetes and ageing: Recent advances in pathogenesis and therapy. Int J Immunopathol Pharmacol 2010;23:997-1003
14. Chao CY, Zheng YP, Cheing GL: Epidermal thickness and biomechanical properties of plantar tissues in diabetic foot. Ultrasound Med Biol 2011;37:1029-1038
15. Birke JA, Franks BD, Foto JG: First ray joint limitation, pressure, and ulceration of the first metatarsal head in diabetes mellitus. Foot Ankle Int 1995;16:277-284
16. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ: Simple non-invasive assessment of advanced glycation end product accumulation. Diabetologia 2004;47:1324-1330
17. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, Gans RO, Bilo HJ: Skin autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 2008;31:517-521
18. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ: Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 2006;29:2654-2659
19. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ: Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007;30:107-112
20. Executive summary: Standards of medical care in diabetes -2013. Diabetes Care 2013;36(Suppl 1):S4-S10
21. Bakker K, Apelqvist J, Schaper NC; International Working Group on Diabetic Foot Editorial Board: Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 2012;28(Suppl 1):225-231
22. Ghanassia E, Villon L, Thuan Dit Dieudonné JF, Boegner C, Avignon A, Sultan A: Long-Term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers: A 6.5-years follow-up study. Diabetes Care 2008;31:1288-1292
23. Niu Y, Cao X, Song F, Xie T, Ji X, Miao M, Dong J, Tian M, Lin Y, Lu S: Reduced dermis thickness and AGE accumulation in diabetic abdominal skin. Int J Low Extrem Wounds 2012;11:224-230
24. Hu H, Han CM, Hu XL, Ye WL, Huang WJ, Smit AJ: Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: A cross-sectional, observational study of Chinese subjects. J Zhejiang Univ Sci B 2012;13:372-377
25. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG: A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999;22:1036-1042
26. Dubský M, Jirkovská A, Bem R, Fejfarová V, Skibová J, Schaper NC, Lipsky BA: Risk factors for recurrence of diabetic foot ulcers: Prospective follow-up analysis of a Eurodiale subgroup. Int Wound J 2012;19:1742-1748
27. Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS: Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 2002;25:1055-1059
28. Kuzuya M, Satake S, Ai S, Asai T, Kanda S, Ramos MA, Miura H, Ueda M, Iguchi A: Inhibition of angiogenesis on glycated collagen lattices. Diabetologia 1998;41:491-499
29. Morita K, Urabe K, Moroi Y, Koga T, Nagai R, Horiuchi S, Furue M: Migration of keratinocytes is impaired on glycated collagen I. Wound Repair Regen 2005;13:93-101
30. Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, Nowygrod S, Wolf BM, Caliste X, Yan SF, Stern DM, Schmidt AM: Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 2001;159:513-525
31. Peppa M, Brem H, Ehrlich P, Zhang JG, Cai W, Li Z, Croitoru A, Thung S, Vlassara H: Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 2003;52:2805-2813
32. Gill SE, Parks WC: Metalloproteinases and their inhibitors: Regulators of wound healing. Int J Biochem Cell Biol 2008;40:1334-1347
33. Lobmann R, Schultz G, Lehnert H: Proteases and the diabetic foot syndrome: Mechanisms and therapeutic implications. Diabetes Care 2005;28:461-471
34. Zhu P, Ren M, Yang C, Hu YX, Ran JM, Yan L: Involvement of RAGE, MAPK and NF-jB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Exp Dermatol 2012;21:123-129